Resources
30 Results (showing 1 - 10)
Results sorted by posted date (newest first)
Results sorted by posted date (newest first)
Posted 10/19/2023 (updated 4/11/2024)
Implementation IV grantees with tools and strategies
Posted 8/18/2023 (updated 3/26/2024)
The National Institute on Drug Abuse (NIDA) Center for the Clinical Trials Network (CCTN) held an event where health care professionals and federal partners discussed xylazine-related testing, treatment, and wound care. As the White House has deemed fentanyl adulterated with xylazine an emerging threat, it is important to identify and adapt to the rapidly changing practices of patient care.
Posted 7/26/2023 (updated 3/28/2024)
As we look back over the past 3 years, stand in the present, and look forward, what emerging leadership approaches will create flourishing in our unique communities? This leadership inquiry encourages celebration, pondering of possibilities in good company, and consideration of leadership pivots.
Posted 6/2/2023 (updated 3/27/2024)
Behavioral health care encompasses a wide variety of interventions delivered by many different types of providers. Although there is a call for expanding direct or indirect behavioral health service systems to care for those affected, in the U.S., nearly all these providers are in short supply.
Posted 4/25/2023 (updated 3/27/2024)
Wish lists for consortiums or coalitions often include words like “effective,” “engaged,” “productive,” “sustainable,” “powerful,” “growing,” and “motivated.”
Posted 4/5/2023 (updated 3/27/2024)
The Northwest Prevention Technology Transfer Center (PTTC) Network has developed an Alcohol Awareness Toolkit to use during Alcohol Awareness Month. The Alcohol Awareness Toolkit will help you raise awareness about alcohol-related harms and the importance of strong alcohol policies. It also encourages engagement from prevention and public health stakeholders to strategically educate and inform decision-makers about effective alcohol policies by providing easy-to-personalize, templated opinion editorials, letters to legislators, and proclamations.
Posted 3/14/2023 (updated 3/27/2024)
Xylazine is a non-opioid that is approved for animals, and not FDA-approved for humans. New York State's Department of Health provides information on what it is, sources and trends, effects, why people use it, why clinicians should be concerned, and other information on Xylazine. Information about Xylazine is important to understand now that it has been showing up in illicit drug supply.
Posted 11/11/2022 (updated 3/27/2024)
OMNI Institute, in partnership with the JBS RCORP-TA team, created the 2022-2023 RCORP-TA Data Learning Collaborative (LC) for grantees to come together and share knowledge, talk through challenges, and build relationships with one another. This LC will build upon the foundation established in the prior 2022 RCORP-TA Data Learning Collaborative.
Posted 10/25/2022 (updated 3/27/2024)
The U.S. Government Accountability Office (GAO) published a new report to Congress on access to obstetric care in rural communities. GAO found that the number of rural hospitals providing obstetric services declined from 2004 through 2018. By 2018 more than half of rural counties lacked OB services. OB closures were focused in rural counties that were sparsely populated, had a majority of Black residents, and were considered low income. GAO interviewed stakeholders to identify the most important factors affecting availability of OB care and the efforts federal agencies, states, and others could take to increase availability of services.
Posted 7/12/2022 (updated 3/27/2024)
Syringe services programs (SSP) are harm reduction programs that provide a wide range of services including, but not typically limited to, the provision of new, unused hypodermic needles and syringes and other injection drug use supplies, such as cookers, tourniquets, alcohol wipes, and sharps waste disposal containers, to people who inject drugs. In this summary, readers will find information with respect to SSPs for each state, including citations to applicable statutes and/or regulations, whether the state allows SSPs by statute, whether there are any municipal or county ordinances or regulations in place within the state, program components, miscellaneous provisions, and information on any pending legislation.